Cytomx Thera (CTMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 43,247 | 36,185 | 17,171 | 26,024 | 57,536 |
| Marketable Securities | 93,935 | 114,099 | 157,338 | 168,086 | 123,322 |
| Receivables | 2,775 | 13,177 | 3,432 | 2,419 | 1,903 |
| TOTAL | $143,080 | $167,247 | $182,936 | $201,204 | $187,801 |
| Non-Current Assets | |||||
| PPE Net | 3,316 | 3,567 | 3,958 | 4,060 | 4,499 |
| Intangibles | 1,605 | 1,642 | 1,678 | 1,715 | 1,751 |
| Other Non-Current Assets | 11,218 | 12,231 | 13,220 | 14,188 | 15,134 |
| TOTAL | $16,139 | $17,440 | $18,856 | $19,963 | $21,384 |
| Total Assets | $159,219 | $184,687 | $201,792 | $221,167 | $209,185 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 611 | 1,964 | 1,458 | 1,705 | 1,029 |
| Accrued Expenses | 13,620 | 14,220 | 17,599 | 20,689 | 20,068 |
| TOTAL | $142,858 | $144,536 | $155,913 | $146,790 | $141,377 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 123,766 | 123,628 | 132,267 | 124,396 | 120,280 |
| Other Non-Current Liabilities | 10,878 | 12,088 | 13,278 | 13,354 | 11,962 |
| TOTAL | $47,588 | $71,831 | $93,326 | $125,615 | $152,835 |
| Total Liabilities | $190,446 | $216,367 | $249,239 | $272,405 | $294,212 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 78,118 | 77,919 | 67,722 | 66,989 | 66,768 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -716,191 | -709,657 | -723,448 | -724,285 | -727,277 |
| Other shareholders' equity | -4 | -10 | 95 | -63 | 35 |
| TOTAL | $-31,227 | $-31,680 | $-47,447 | $-51,238 | $-85,027 |
| Total Liabilities And Equity | $159,219 | $184,687 | $201,792 | $221,167 | $209,185 |